Advice
Following a full submission
Eflornithine 11.5% cream (Vaniqa) is not recommended for use within NHS Scotland for the treatment of facial hirsutism in woman. There is no evidence of its efficacy in comparison to existing treatments and it is substantially more expensive.
The licence holder has indicated their decision to resubmit.
Download detailed advice43KB (PDF)
Medicine details
- Medicine name:
- Eflornithine 11.5% cream (Vaniqa®)
- SMC ID:
- 159/05
- Indication:
- Facial hirsutism in woman
- Pharmaceutical company
- Shire Pharmaceuticals
- BNF chapter
- Skin
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 09 May 2005